Overall, these results suggested that SIV could alleviate oxidant damage and inflammation in ALI rats by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways. The gene discussed is NFE2L2; the disease is acute respiratory distress syndrome.